Company news
Lepu Biopharma Co. Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Voluntary announcement increase in shareholding by the controlling shareholder
October 27, 2026
Voluntary announcement CMG901 (AZD0901) clinical results presented as lba proffered paper at presidential symposium, MRG007 clinical results presented as lba, and encouraging data for MRG003 presented as rapid oral at esmo 2026
October 26, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
Voluntary announcement four clinical studies selected for presentation at 2026 ESMO congress: CMG901 (AZD0901) clinical trial results selected as LBA for proffered paper presentation at Presidential Symposium, MRG007 clinical trial results selected as LBA for rapid oral presentation, and two other studies selected for rapid oral presentation
September 23, 2026
2026 Interim Report
September 16, 2026
BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC
November 21, 2025